Alzheimer's disease: From immunotherapy to immunoprevention
Cell,
Recent Aβ-immunotherapy trials demonstrated that removing aggregated Aβ from the brains of symptomatic patients can slow…
Recent Aβ-immunotherapy trials demonstrated that removing aggregated Aβ from the brains of symptomatic patients can slow…
An experimental Alzheimer’s disease drug called BAN2401 has generated intriguing additional results in a a Phase II clinical…